EE200300028A - (R)-N-[5-metüül-8-(4-metüülpiperasiin-1-üül)-1,2,3,4-tetrahüdro-2-naftüül]-4-morfolin obensamiidi uus vorm, meetod selle saamiseks ning kasutamine - Google Patents
(R)-N-[5-metüül-8-(4-metüülpiperasiin-1-üül)-1,2,3,4-tetrahüdro-2-naftüül]-4-morfolin obensamiidi uus vorm, meetod selle saamiseks ning kasutamineInfo
- Publication number
- EE200300028A EE200300028A EEP200300028A EEP200300028A EE200300028A EE 200300028 A EE200300028 A EE 200300028A EE P200300028 A EEP200300028 A EE P200300028A EE P200300028 A EEP200300028 A EE P200300028A EE 200300028 A EE200300028 A EE 200300028A
- Authority
- EE
- Estonia
- Prior art keywords
- methyl
- morpholinobenzamide
- piperazin
- tetrahydro
- naphthyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Reproductive Health (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0002729A SE0002729D0 (sv) | 2000-07-20 | 2000-07-20 | Novel compound form |
| PCT/SE2001/001643 WO2002008212A1 (en) | 2000-07-20 | 2001-07-17 | Novel form of (r)-n-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200300028A true EE200300028A (et) | 2004-10-15 |
Family
ID=20280557
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200300028A EE200300028A (et) | 2000-07-20 | 2001-07-17 | (R)-N-[5-metüül-8-(4-metüülpiperasiin-1-üül)-1,2,3,4-tetrahüdro-2-naftüül]-4-morfolin obensamiidi uus vorm, meetod selle saamiseks ning kasutamine |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6706710B2 (es) |
| EP (1) | EP1305303A1 (es) |
| JP (1) | JP2004504390A (es) |
| KR (1) | KR20030015398A (es) |
| CN (1) | CN1443178A (es) |
| AR (1) | AR029588A1 (es) |
| AU (2) | AU2001272872B2 (es) |
| BR (1) | BR0112619A (es) |
| CA (1) | CA2415046A1 (es) |
| CZ (1) | CZ2003140A3 (es) |
| EE (1) | EE200300028A (es) |
| HU (1) | HUP0301116A3 (es) |
| IL (1) | IL153836A0 (es) |
| IS (1) | IS6679A (es) |
| MX (1) | MXPA03000439A (es) |
| NO (1) | NO20030220L (es) |
| NZ (1) | NZ523528A (es) |
| PL (1) | PL365112A1 (es) |
| RU (1) | RU2002135626A (es) |
| SE (1) | SE0002729D0 (es) |
| SK (1) | SK732003A3 (es) |
| UA (1) | UA72333C2 (es) |
| WO (1) | WO2002008212A1 (es) |
| ZA (1) | ZA200300129B (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI488854B (zh) | 2008-06-20 | 2015-06-21 | Astrazeneca Ab | 二苯并噻氮呯衍生物及其用途 |
| GB201111705D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Compounds and their use |
| GB201111704D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Novel compounds |
| JO3115B1 (ar) | 2011-08-22 | 2017-09-20 | Takeda Pharmaceuticals Co | مركبات بيريدازينون واستخدامها كمثبطات daao |
| GB201209587D0 (en) | 2012-05-30 | 2012-07-11 | Takeda Pharmaceutical | Therapeutic compounds |
| EP3010900B1 (en) | 2013-06-21 | 2018-01-03 | Takeda Pharmaceutical Company Limited | 1-sulfonyl piperidine derivatives as modulators of prokineticin receptors |
| GB201314286D0 (en) | 2013-08-08 | 2013-09-25 | Takeda Pharmaceutical | Therapeutic Compounds |
| GB201318222D0 (en) | 2013-10-15 | 2013-11-27 | Takeda Pharmaceutical | Novel compounds |
| GB201320905D0 (en) | 2013-11-27 | 2014-01-08 | Takeda Pharmaceutical | Therapeutic compounds |
| TW201613864A (en) | 2014-02-20 | 2016-04-16 | Takeda Pharmaceutical | Novel compounds |
| GB201616839D0 (en) | 2016-10-04 | 2016-11-16 | Takeda Pharmaceutical Company Limited | Therapeutic compounds |
| GB201619514D0 (en) | 2016-11-18 | 2017-01-04 | Takeda Pharmaceuticals Co | Novel compounds |
| JP2021138648A (ja) | 2020-03-04 | 2021-09-16 | 武田薬品工業株式会社 | 経口固形製剤 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9601110D0 (sv) * | 1996-03-22 | 1996-03-22 | Astra Ab | Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| SE9900190D0 (sv) * | 1999-01-22 | 1999-01-22 | Astra Ab | New compounds |
| SE9702799D0 (sv) | 1997-07-25 | 1997-07-25 | Astra Ab | New compounds |
-
2000
- 2000-07-20 SE SE0002729A patent/SE0002729D0/xx unknown
-
2001
- 2001-07-10 AR ARP010103259A patent/AR029588A1/es not_active Application Discontinuation
- 2001-07-17 JP JP2002514118A patent/JP2004504390A/ja active Pending
- 2001-07-17 UA UA20021210561A patent/UA72333C2/uk unknown
- 2001-07-17 WO PCT/SE2001/001643 patent/WO2002008212A1/en not_active Application Discontinuation
- 2001-07-17 CN CN01813106A patent/CN1443178A/zh active Pending
- 2001-07-17 BR BR0112619-9A patent/BR0112619A/pt not_active IP Right Cessation
- 2001-07-17 EP EP01952077A patent/EP1305303A1/en not_active Withdrawn
- 2001-07-17 AU AU2001272872A patent/AU2001272872B2/en not_active Expired - Fee Related
- 2001-07-17 SK SK73-2003A patent/SK732003A3/sk unknown
- 2001-07-17 MX MXPA03000439A patent/MXPA03000439A/es unknown
- 2001-07-17 EE EEP200300028A patent/EE200300028A/xx unknown
- 2001-07-17 KR KR10-2003-7000799A patent/KR20030015398A/ko not_active Application Discontinuation
- 2001-07-17 RU RU2002135626/04A patent/RU2002135626A/ru not_active Application Discontinuation
- 2001-07-17 AU AU7287201A patent/AU7287201A/xx active Pending
- 2001-07-17 IL IL15383601A patent/IL153836A0/xx unknown
- 2001-07-17 HU HU0301116A patent/HUP0301116A3/hu unknown
- 2001-07-17 CA CA002415046A patent/CA2415046A1/en not_active Abandoned
- 2001-07-17 US US10/333,286 patent/US6706710B2/en not_active Expired - Fee Related
- 2001-07-17 NZ NZ523528A patent/NZ523528A/en unknown
- 2001-07-17 CZ CZ2003140A patent/CZ2003140A3/cs unknown
- 2001-07-17 PL PL01365112A patent/PL365112A1/xx not_active Application Discontinuation
-
2003
- 2003-01-06 ZA ZA200300129A patent/ZA200300129B/en unknown
- 2003-01-14 IS IS6679A patent/IS6679A/is unknown
- 2003-01-16 NO NO20030220A patent/NO20030220L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20030015398A (ko) | 2003-02-20 |
| HUP0301116A2 (hu) | 2003-08-28 |
| RU2002135626A (ru) | 2004-07-27 |
| NZ523528A (en) | 2004-09-24 |
| MXPA03000439A (es) | 2003-06-24 |
| PL365112A1 (en) | 2004-12-27 |
| IL153836A0 (en) | 2003-07-31 |
| WO2002008212A1 (en) | 2002-01-31 |
| SK732003A3 (en) | 2003-08-05 |
| IS6679A (is) | 2003-01-14 |
| BR0112619A (pt) | 2003-07-29 |
| CA2415046A1 (en) | 2002-01-31 |
| CN1443178A (zh) | 2003-09-17 |
| AR029588A1 (es) | 2003-07-02 |
| EP1305303A1 (en) | 2003-05-02 |
| AU7287201A (en) | 2002-02-05 |
| AU2001272872B2 (en) | 2005-08-25 |
| ZA200300129B (en) | 2004-06-25 |
| US20030166653A1 (en) | 2003-09-04 |
| NO20030220D0 (no) | 2003-01-16 |
| NO20030220L (no) | 2003-03-14 |
| HUP0301116A3 (en) | 2006-03-28 |
| UA72333C2 (en) | 2005-02-15 |
| JP2004504390A (ja) | 2004-02-12 |
| CZ2003140A3 (cs) | 2003-06-18 |
| SE0002729D0 (sv) | 2000-07-20 |
| US6706710B2 (en) | 2004-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE200300325A (et) | Asendatud amiini derivaadid ning nende kasutamismeetodid | |
| NO20031923D0 (no) | Ny behandling av "restless legs" syndrom | |
| CY2012009I1 (el) | Αναστολεις της κυκλοπροπυλ-συντηκωμενης διπεπτυλοπεπτιδασης 4, βασισμενοι σε πυρρολιδινη, και μεθοδοι για την παρασκευη των και την χρηση των | |
| ATE431412T1 (de) | Antikörper gegen il-12, zusammensetzungen, verfahren und verwendungen | |
| EE200300028A (et) | (R)-N-[5-metüül-8-(4-metüülpiperasiin-1-üül)-1,2,3,4-tetrahüdro-2-naftüül]-4-morfolin obensamiidi uus vorm, meetod selle saamiseks ning kasutamine | |
| DE60133303D1 (de) | Halbleitergrundmaterial und verfahren zu seiner herstellung | |
| DE60101069D1 (de) | Siliziumkarbid und Verfahren zu seiner Herstellung | |
| DE60231762D1 (de) | Zusammensetzungen zum Reinigen und Desinfizierten von harten Oberflächen | |
| DE60217363D1 (de) | 17beta-hydroxysteroid dehydrogenase type 3 inhibitoren zur behandlung von androgen-abhängigen erkrankungen | |
| HRP20040977A2 (en) | Derivatives of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics | |
| EE200300134A (et) | Uued tiadiasoolid ja oksadiasoolid ning nende kasutamine fosfodiesteraas-7 inhibiitoritena | |
| CY2009017I2 (el) | Μεθοδος για την παρασκευη 10, 11-διυδρο-10-υδροξυ-5η-διβενζο/β,f/αζεπινο-5-καρβοξαμιδιου και 10,11-διυδρο-10-οξο-5η-διβενζο/β,f/αζεπινο-5-καρβοξαμιδιου | |
| DE60105218D1 (de) | Siliciumkarbid und Verfahren zu seiner Herstellung | |
| DE60307766D1 (de) | Gewürzmittel und Verfahren zu seiner Herstellung | |
| DE50203297D1 (de) | Mischungen aus wachsen und polymeradditiven | |
| ATE471315T1 (de) | Piperidin- und piperazinacetamide als inhibitoren der 17beta-hydroxysteroiddehydrogenase des typs 3 zur behandlung androgenabhängiger krankheiten | |
| DE60125347D1 (de) | Nitrilkautschukzusammensetzung, vulkanisierbare nitrilkautschukzusammensetzung und vulkanisat | |
| DE60112581D1 (de) | Zusammensetzungen zur behandlung baktrieller infektionen, welche ein oxazolidinonderivat, sulbactam und ampicillin enthalten | |
| ATE273276T1 (de) | Cyclobutendion-derivate zur behandlung von artherosclerose | |
| EE200200167A (et) | Sünteetiline nahk, meetod selle valmistamiseks ning kasutamine | |
| WO2002046156A3 (en) | 4,4-DISUBSTITUTED PIPERIDINES AND THEIR METHODS OF USE | |
| DE60327928D1 (de) | Herstellung von homopolymeren, copolymeren und terpolymeren aus substituierten styrolen | |
| EE200200583A (et) | (E)-N-(6,6-dimetüül-2-hepteen-4-ünüül)-N-metüül-1-naftaleenmetaanamiini (terbinafiin) valmistamise meetod | |
| DE60302781D1 (de) | Hydrolysebeständige zusammensetzungen aus polyesterelastomeren, daraus hergestellte artikel und verfahren | |
| DE60208551D1 (de) | Verfahren zur herstellung von racemischen und enantiomerenreinen derivaten von 1,5-diaryl-3-trifluormethyl-delta2-pyrazolinen |